Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver.
about
Inflammation- and stress-related signaling pathways in hepatocarcinogenesisLeptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study.Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.Evolution in the treatment of metastatic colorectal carcinoma of the liverInterleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?Interleukin 6 and liver regenerationLCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration.Principles of liver regeneration and growth homeostasis.Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulationNon alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regeneration.Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.Rat hepatocytes weighted gene co-expression network analysis identifies specific modules and hub genes related to liver regeneration after partial hepatectomyThe development and compensation of biliary cirrhosis in interleukin-6-deficient mice.Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling.Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway.Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinomaFrequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumoursLiver stem cells and tgf-Beta in hepatic carcinogenesis.Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress responseIL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.gp130: a promising drug target for cancer therapy.Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling.The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome.Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease.Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver.Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotectionThe mitogenic activity of hepatocyte growth factor on rat hepatocytes is dependent upon endogenous transforming growth factor-alpha.Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic mice.The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6.Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor.Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma.Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference.Possible role of human interleukin-6 and soluble interleukin-6 receptor in hepatitis B virus infection.
P2860
Q28387669-3A03A80F-4E72-4799-8CAB-D749ADC196F5Q33688663-87ADBA7C-57CC-441D-A65D-FACA2969570CQ33716459-6CC5576E-AB0B-4096-9FBC-44F1216E2271Q33868416-A5AA833A-A5BD-4580-9E5C-5202C96371F9Q33868508-D916D99B-CB5C-45DD-863F-E66EE2891C90Q33921803-4CD6480F-50C7-4F4E-9293-E35488655127Q33969763-1D642187-34D3-4D71-87B8-5A66818B5FAEQ34338137-5D906534-92FF-49E7-8649-CD59650E96CFQ34347580-9501794E-FF7D-4DAA-9B8E-6BF997EB94FAQ34467311-25FBECB9-F296-466B-9257-ED7A99E24AD2Q34472475-8E8A23EF-643A-40FE-90E9-0DA476634301Q34589677-F345113C-2BE2-40B4-9629-65FAB5321269Q34756517-44FDECE5-41E3-4521-85E5-A15AF095ED1DQ34881846-1843C873-0B5E-4E85-99D8-8931F01C73B5Q35151921-8B49E730-9ED5-46C0-8208-773B1E53E3F9Q35810127-01870D82-F252-4117-B379-2F127D89AD79Q36497297-E2993753-0A93-422C-89CD-F07C7704CC2BQ36983666-6E8AF130-3C7A-46EA-8C7F-DFD6F2288584Q37064043-ABBF8C8E-6E37-4F1C-83ED-BD4B3CE3D6B2Q37224637-9C4FCC4E-9DF9-46A7-9065-C9EC2095811CQ37431530-CB6D3F72-719B-47E7-B881-CF6547CCD684Q37688291-57E04E90-54FE-44AD-BA2A-84D085383466Q38058509-DA8C71B1-F455-476C-AA50-803A2036108BQ38149939-7B19C170-647B-4834-9E89-9A1F66AED8A3Q38294966-4899CB5D-07F2-4074-A85A-5C8B78425DD1Q38356626-09612DEC-972E-4E42-A7EB-2B86F861DB9AQ38658328-C1370921-D02D-4EB1-B630-74CFE1EAC31DQ39293308-2D51F5EF-EF01-46AB-B782-A5786D9CDCA0Q39457251-0D0975C4-B905-420D-A96C-2E7B3BA001AEQ40444774-5448E161-AE3D-44F7-B79C-B452984B8FE3Q40891444-3D01A3BC-862E-4ABE-9767-8C9040FC04D3Q41492239-7C47ACE4-C47B-457C-8B39-055116EA22D9Q42048597-5E264E85-FD3C-4D75-8578-2E7DF7AC0298Q42503180-44827F05-14D6-49E0-945A-806FDF24C3CDQ42757104-CB31A428-8967-4281-AF80-CF8EA94B0995Q43583391-98F4964D-3D60-4934-8782-72478238E978Q43762936-78C186C8-F22C-4B19-8612-F1E8F044F4DBQ44124129-F92B1DFF-8020-4254-B555-5A0C0F0D9A3BQ45237933-210C3A77-1DBF-490D-8701-F77F5D18A497Q45737156-C93BD189-610C-4ED5-91A6-960FF225E5F1
P2860
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Coexpression of IL-6 and solub ...... sia and adenomas of the liver.
@ast
Coexpression of IL-6 and solub ...... sia and adenomas of the liver.
@en
type
label
Coexpression of IL-6 and solub ...... sia and adenomas of the liver.
@ast
Coexpression of IL-6 and solub ...... sia and adenomas of the liver.
@en
prefLabel
Coexpression of IL-6 and solub ...... sia and adenomas of the liver.
@ast
Coexpression of IL-6 and solub ...... sia and adenomas of the liver.
@en
P2093
P2860
P50
P356
P1433
P1476
Coexpression of IL-6 and solub ...... asia and adenomas of the liver
@en
P2093
Di Carlo E
P2860
P304
P356
10.1093/EMBOJ/17.19.5588
P407
P577
1998-10-01T00:00:00Z